Riyadh to host global biotech summit in September

Saudi Arabia will bring more than 100 speakers and delegates from over 70 countries to Riyadh for the Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026. The event is designed to advance the kingdom’s biotech strategy, attract investment and showcase research, manufacturing and regulatory capacity.

Why it matters: - The Riyadh Global Medical Biotechnology Summit is meant to help Saudi Arabia build a broader biotech ecosystem, not just host a conference. - The summit supports the kingdom’s National Biotechnology Strategy, which targets a $34.6 billion contribution to non-oil GDP by 2040. - Organizers expect the event to connect research, investment, regulation and manufacturing in one place.

What happened: - Riyadh will host the fourth Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026. - More than 15,000 visitors are expected over the three-day event. - More than 100 local and international speakers are slated to participate. - Delegations from more than 70 countries are expected to attend. - The summit is organized around six themes: artificial intelligence in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and biotech workforce development.

The details: - Organizers say the summit will feature 200 biotechnology and health brands and more than 80 exhibiting organizations from government and industry. - More than 65 agreements and memorandums of understanding are expected during the three days. - The scientific program spans population genomics, AI-driven drug discovery, domestic biomanufacturing, regulatory science, commercialization and investment. - The summit is overseen by Saudi Arabia’s Ministry of National Guard, through its Health Affairs sector. - KAIMRC and King Saud bin Abdulaziz University for Health Sciences are hosting the event. - The Investment Ministry, Invest Saudi and SADAIA are strategic lead partners. - Registration is open for delegates, exhibitors and industry partners at the summit website. - The event is being promoted under the hashtag #RGMBS2026.

Between the lines: - Saudi Arabia is using the summit to signal that it wants to move from idea generation to a full biotech value chain, including research, trials, manufacturing and commercialization. - The program is also a platform to highlight international partnerships, including collaborations with Harvard University in translational oncology, AstraZeneca in gene therapy and Peking University in drug discovery. - The emphasis on infrastructure and talent suggests the kingdom sees people, labs and digital systems as key bottlenecks to biotech growth.

What's next: - Delegates will spend the summit on scientific sessions, panel discussions, workshops and signing ceremonies. - International attendees are expected to review Saudi Arabia’s regulatory frameworks, manufacturing infrastructure and translational research capacity. - The event will test Saudi Arabia’s ability to convert high-level biotech ambitions into partnerships and deals.

The bottom line: - Riyadh is positioning RGMBS 2026 as a deal-making and ecosystem-building event for global biotech, with policy, research and investment all on the agenda.